NeuroOne Medical Technologies (NMTC) Competitors $0.72 +0.02 (+2.62%) Closing price 04:00 PM EasternExtended Trading$0.72 -0.01 (-1.04%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NMTC vs. RCEL, LAKE, INFU, AVR, PTHL, MGRM, LUCD, OBIO, LUNG, and ICADShould you be buying NeuroOne Medical Technologies stock or one of its competitors? The main competitors of NeuroOne Medical Technologies include Avita Medical (RCEL), Lakeland Industries (LAKE), InfuSystem (INFU), Anteris Technologies Global (AVR), Pheton (PTHL), Monogram Orthopaedics (MGRM), Lucid Diagnostics (LUCD), Orchestra BioMed (OBIO), Pulmonx (LUNG), and icad (ICAD). These companies are all part of the "medical equipment" industry. NeuroOne Medical Technologies vs. Its Competitors Avita Medical Lakeland Industries InfuSystem Anteris Technologies Global Pheton Monogram Orthopaedics Lucid Diagnostics Orchestra BioMed Pulmonx icad NeuroOne Medical Technologies (NASDAQ:NMTC) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Is NMTC or RCEL more profitable? NeuroOne Medical Technologies has a net margin of -75.41% compared to Avita Medical's net margin of -79.61%. NeuroOne Medical Technologies' return on equity of -334.64% beat Avita Medical's return on equity.Company Net Margins Return on Equity Return on Assets NeuroOne Medical Technologies-75.41% -334.64% -124.42% Avita Medical -79.61%-632.62%-71.72% Which has better valuation & earnings, NMTC or RCEL? NeuroOne Medical Technologies has higher earnings, but lower revenue than Avita Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroOne Medical Technologies$3.45M10.45-$12.32M-$0.22-3.29Avita Medical$64.25M2.19-$61.85M-$2.19-2.43 Do analysts prefer NMTC or RCEL? NeuroOne Medical Technologies presently has a consensus target price of $1.45, indicating a potential upside of 100.41%. Avita Medical has a consensus target price of $16.50, indicating a potential upside of 209.57%. Given Avita Medical's higher probable upside, analysts clearly believe Avita Medical is more favorable than NeuroOne Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Avita Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do insiders and institutionals have more ownership in NMTC or RCEL? 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 8.9% of NeuroOne Medical Technologies shares are owned by company insiders. Comparatively, 2.8% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer NMTC or RCEL? In the previous week, NeuroOne Medical Technologies had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for NeuroOne Medical Technologies and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 1.87 beat NeuroOne Medical Technologies' score of 0.94 indicating that Avita Medical is being referred to more favorably in the news media. Company Overall Sentiment NeuroOne Medical Technologies Positive Avita Medical Very Positive Which has more volatility and risk, NMTC or RCEL? NeuroOne Medical Technologies has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, Avita Medical has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500. SummaryNeuroOne Medical Technologies and Avita Medical tied by winning 8 of the 16 factors compared between the two stocks. Get NeuroOne Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMTC vs. The Competition Export to ExcelMetricNeuroOne Medical TechnologiesMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.12M$7.13B$5.52B$9.32BDividend YieldN/A2.89%4.25%4.05%P/E Ratio-3.2924.4628.1519.68Price / Sales10.4536.87438.33100.29Price / CashN/A25.3335.5357.53Price / Book24.128.218.235.67Net Income-$12.32M$236.06M$3.23B$257.51M7 Day Performance-2.23%-2.05%-0.01%0.52%1 Month Performance19.73%0.95%5.61%8.84%1 Year Performance-22.43%18.91%26.52%14.18% NeuroOne Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMTCNeuroOne Medical Technologies2.7503 of 5 stars$0.72+2.6%$1.45+100.4%-28.8%$35.12M$3.45M-3.2920RCELAvita Medical1.3545 of 5 stars$5.51+6.6%$16.50+199.5%-45.7%$145.63M$64.25M-2.52130Positive NewsLAKELakeland Industries4.8452 of 5 stars$14.69+2.7%$26.00+77.0%-40.4%$139.78M$177.65M-4.882,100INFUInfuSystem3.1131 of 5 stars$6.23-0.3%$13.00+108.7%N/A$130.93M$137.58M103.85410AVRAnteris Technologies GlobalN/A$3.53+1.4%$16.50+367.4%N/A$127.30M$2.49M0.00138Gap UpPTHLPhetonN/A$19.10-2.3%N/AN/A$125.68M$450K0.0011High Trading VolumeMGRMMonogram Orthopaedics1.0437 of 5 stars$3.24+11.3%$5.40+66.7%+173.1%$115.63MN/A-7.2028LUCDLucid Diagnostics2.5931 of 5 stars$1.06+1.9%$3.55+234.9%+32.9%$114.68M$4.35M-0.7970News CoverageAnalyst ForecastOBIOOrchestra BioMed2.9189 of 5 stars$2.94+1.7%$14.20+383.0%-65.8%$112.63M$2.64M-1.654LUNGPulmonx3.4588 of 5 stars$2.78+5.3%$11.53+314.6%-65.2%$111.92M$83.79M-1.93250News CoverageICADicad0.6885 of 5 stars$3.74+0.8%N/A+198.4%$102.74M$19.53M-19.68140News CoverageGap Up Related Companies and Tools Related Companies RCEL Competitors LAKE Competitors INFU Competitors AVR Competitors PTHL Competitors MGRM Competitors LUCD Competitors OBIO Competitors LUNG Competitors ICAD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMTC) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredTrump has to finance $21 trillion. Here’s His Move…Trump needs $21 trillion to fund his agenda — and insiders believe he’s quietly preparing a major shift in the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTC Stock Alerts